4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Coccidioidomycosis: new trials by email Literature Review of Coccidioidomycosis trials Research Report on Coccidioidomycosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole SUBA itraconazole, Conventional itraconazole - Invasive Fungal Infections | Phase 2 / Phase 3 | Completed | University of Alabama at Birmingham | 88 | 2018-09-17 | 2023-07-07 |
| Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment Ibrexafungerp - Invasive Candidiasis, Mucocutaneous Candidiasis | Phase 3 | Completed | Scynexis, Inc. | 233 | 2017-04-01 | 2024-11-20 |
| POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) Posaconazole, Fluconazole - Coccidioidomycosis | Phase 3 | Completed | Merck Sharp & Dohme LLC | 16 | 2007-05-01 | 2017-04-11 |
| A Multi-center Study of Spherule-Derived Coccidioidin Spherule-derived coccidioidin - Coccidioidomycosis | Phase 3 | Completed | Nielsen BioSciences, Inc. | 113 | 2005-05-01 | 2013-10-29 |
Blastomycosis (2) · Histoplasmosis (2) · Aspergillosis, Allergic Bronchopulmonary (1) · Candidiasis, Chronic Mucocutaneous (1) · Candidiasis, Invasive (1) · Candidiasis, Vulvovaginal (1) · Invasive Fungal Infections (1) · Invasive Pulmonary Aspergillosis (1)
Bacterial Infections and Mycoses (4) · Infections (4) · Mycoses (4) · Dermatomycoses (2) · Lung Diseases (2) · Lung Diseases, Fungal (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Skin Diseases (2) · Skin Diseases, Infectious (2) · Skin and Connective Tissue Diseases (2) · Aspergillosis (1) · Candidiasis (1) · Chronic Disease (1) · Disease Attributes (1)
Fluconazole (1) · Itraconazole (1) · ibrexafungerp (1) · posaconazole (1)
Merck Sharp & Dohme LLC (1) · Nielsen BioSciences, Inc. (1) · Scynexis, Inc. (1) · University of Alabama at Birmingham (1)
United States (3) · Austria (1) · Germany (1) · Netherlands (1) · Pakistan (1) · Panama (1) · South Africa (1) · Spain (1) · United Kingdom (1)
Andrej Spec, MD (1) · Brad Sawtelle, M.D. (1) · George R Thompson, MD (1) · Harry S Nielsen, Ph.D. (1) · Neil Ampel, M.D. (1) · Peter G Pappas, MD (1) · Royce Johnson, M.D. (1) · Stephen Kernerman, D.O. (1)
2017 (1)